MedPath

Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung Adenocarcinoma

Conditions
Glycolysis
Diagnosis
Lung Cancer
Survival
Interventions
Diagnostic Test: Diagnostic test
Registration Number
NCT03641105
Lead Sponsor
Shanghai Zhongshan Hospital
Brief Summary

Detect the contents of glucose metabolism molecules in the tumor and adjacent normal samples of about 100 patients with lung adenocarcinoma using mass spectroscopy. Analyze the correlation between the contents and the clinicopathological characteristics and survival.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Primary lung adenocarcinoma
Exclusion Criteria
  • Other tumor histories, received radiotherapy or chemotherapy before surgery, tumor or adjacent normal tissues can't be obtained, patient rejected.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
lung adenocarcinomaDiagnostic testpatients with lung adenocarcinoma
Primary Outcome Measures
NameTimeMethod
disease-free survival1 month

disease-free survival

Secondary Outcome Measures
NameTimeMethod
overall survival1 month

overall survival

© Copyright 2025. All Rights Reserved by MedPath